Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

August 5, 2021 13:12:07
  • GPFT forms strategic alliance with 6PAK Solutions Inc
  • Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021
  • Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids
In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too ( “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take the initial steps toward obtaining Canadian regulatory approval to bring Grapefruit’s patented time-release THC+CBD topical delivery cream to all Canadians,” said Grapefruit CEO and cofounder Bradley J. Yourist. “6PAK Solutions’ expertise in this area is unrivaled and assures Grapefruit will bring a fully compliant cannabis product to market in Canada. 6PAK is a subsidiary of ATG Pharma, Inc., a leader in regulatory-compliant filling and packaging for the cannabis industry in Canada, so we are in good hands indeed. Our team looks forward to working with Chris Shar and his team in the coming weeks to achieve our corporate goal of introducing Hourglass across the entire nation of Canada in the third quarter of 2021.” Late last month, Grapefruit announced that it had formed a strategic alliance with 6PAK, a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. According to the agreement, GPFT will file a Notice of New Cannabis Product (“NNCP”) with Health Canada; the NNCP outlines the Hourglass production process including the integration of Grapefruit’s patented Z-Pod Xerogel Silica Gel technology into the Hourglass topical delivery cream system. The company hopes to receive approval of the NNCP by third quarter 2021. Once approval is received, the company will work with 6PAK to launch its exclusive Hourglass Time Release THC+CBD Delivery Topical Relief Cream in the Canadian market. “With our strong roots in the Canadian market and service-focused approach, we are proud to offer a platform for Hourglass to bring new and innovative products to the Canadian consumer,” said 6PAK cofounder Chris Shar. Grapefruit’s patented Hourglass delivery cream system is a powerful disruptive delivery technology that has fundamentally changed the way humans absorb cannabinoids such as THC and CBD. Improved absorption means improved benefits, and THC and CBD are purported to provide a host of holistic advantages. A simple application of Grapefruit’s Hourglass cream on the skin is all that is needed for users to enjoy the full-body entourage effects and related relief provided by THC and other beneficial cannabinoids. Because Grapefruit is the exclusive licensee of the Z-Pod Xerogel Silica Gel for cannabis products in North America and the only company that knows how to manufacture the Hourglass time-release delivery cream using the xerogel gel, the company can lay claim to the unique benefits the cream provides. Joining the Grapefruit team, which notes that Hourglass is the future of healthy cannabis delivery systems, are its approved retailers located throughout the United States, Canada and Mexico. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. The company’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. To find out more about the company and its game-changing Hourglass time-release cannabinoid delivery cream, please visit NOTE TO INVESTORS: The latest news and updates relating to GPFT are available in the company’s newsroom at About CBDWire CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge. To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only) For more information please visit Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: Do you have questions or are you interested in working with CNW? Ask Our Editor CBDWire (CBDW) Denver, Colorado 303.498.7722 Office CBDWire is part of the InvestorBrandNetwork.